DDInter820 DDInter1082
Ginseng is promoted as an adaptogen (a product that increases the body's resistance to stress), one which can to a certain extent be supported with reference to its anticarcinogenic and antioxidant properties. Ginseng is also known to contain phytoestrogens.
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type II diabetes mellitus (T2DM). It is sold by Sanofi-Aventis under the brand name Adlyxin in the US and Lyxumia in the EU. Adlyxin recieved FDA approval July 28, 2016.
Ginseng {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Glimepiride
Ginseng {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Ticagrelor
Ginseng {u} may lead to a major life threatening interaction when taken with {v} Imatinib
Ginseng may cause a moderate interaction that could exacerbate diseases when taken with Glimepiride
Ginseng may cause a moderate interaction that could exacerbate diseases when taken with Ticagrelor
Ginseng may lead to a major life threatening interaction when taken with Imatinib